SMTL ID : 1oyx.1

CRYSTAL STRUCTURE OF 3-MBT REPEATS OF LETHAL (3) MALIGNANT BRAIN TUMOR (SELENO-MET) AT 1.85 ANGSTROM

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.85 Å

Oligo State

homo-9-mer

Ligands

42 x SO4: SULFATE ION(Non-functional Binders)

SO4.1: 3 residues within 4Å: Chain A: H.286, G.289, W.290 Ligand excluded by PLIP SO4.2: 5 residues within 4Å: Chain A: E.101, S.119, W.120, S.121 Chain G: K.39 Ligand excluded by PLIP SO4.3: 3 residues within 4Å: Chain A: P.133, K.134, H.135 Ligand excluded by PLIP SO4.4: 2 residues within 4Å: Chain A: R.264, H.302 Ligand excluded by PLIP SO4.7: 4 residues within 4Å: Chain B: Y.79, S.80, H.83, K.111 Ligand excluded by PLIP SO4.8: 3 residues within 4Å: Chain B: H.286, D.288, G.289 Ligand excluded by PLIP SO4.9: 3 residues within 4Å: Chain A: K.246 Chain B: S.291, H.292 Ligand excluded by PLIP SO4.10: 2 residues within 4Å: Chain B: R.264, H.302 Ligand excluded by PLIP SO4.11: 4 residues within 4Å: Chain B: P.25, V.26 Chain G: S.291, Y.294 Ligand excluded by PLIP SO4.12: 4 residues within 4Å: Chain B: E.101, S.119, W.120, S.121 Ligand excluded by PLIP SO4.16: 5 residues within 4Å: Chain A: P.250 Chain C: Y.79, S.80, H.83, K.111 Ligand excluded by PLIP SO4.17: 9 residues within 4Å: Chain C: R.160, W.193, C.194, D.195, S.198, Y.200, R.248, D.299, D.301 Ligand excluded by PLIP SO4.18: 3 residues within 4Å: Chain C: S.119, W.120, S.121 Ligand excluded by PLIP SO4.19: 3 residues within 4Å: Chain C: K.102, K.134, H.142 Ligand excluded by PLIP SO4.22: 3 residues within 4Å: Chain D: H.286, G.289, W.290 Ligand excluded by PLIP SO4.23: 4 residues within 4Å: Chain D: E.101, S.119, W.120, S.121 Ligand excluded by PLIP SO4.24: 3 residues within 4Å: Chain D: P.133, K.134, H.135 Ligand excluded by PLIP SO4.25: 2 residues within 4Å: Chain D: R.264, H.302 Ligand excluded by PLIP SO4.28: 4 residues within 4Å: Chain E: Y.79, S.80, H.83, K.111 Ligand excluded by PLIP SO4.29: 3 residues within 4Å: Chain E: H.286, D.288, G.289 Ligand excluded by PLIP SO4.30: 3 residues within 4Å: Chain D: K.246 Chain E: S.291, H.292 Ligand excluded by PLIP SO4.31: 2 residues within 4Å: Chain E: R.264, H.302 Ligand excluded by PLIP SO4.32: 2 residues within 4Å: Chain E: P.25, V.26 Ligand excluded by PLIP SO4.33: 4 residues within 4Å: Chain E: E.101, S.119, W.120, S.121 Ligand excluded by PLIP SO4.37: 5 residues within 4Å: Chain D: P.250 Chain F: Y.79, S.80, H.83, K.111 Ligand excluded by PLIP SO4.38: 9 residues within 4Å: Chain F: R.160, W.193, C.194, D.195, S.198, Y.200, R.248, D.299, D.301 Ligand excluded by PLIP SO4.39: 3 residues within 4Å: Chain F: S.119, W.120, S.121 Ligand excluded by PLIP SO4.40: 3 residues within 4Å: Chain F: K.102, K.134, H.142 Ligand excluded by PLIP SO4.43: 3 residues within 4Å: Chain G: H.286, G.289, W.290 Ligand excluded by PLIP SO4.44: 5 residues within 4Å: Chain D: K.39 Chain G: E.101, S.119, W.120, S.121 Ligand excluded by PLIP SO4.45: 3 residues within 4Å: Chain G: P.133, K.134, H.135 Ligand excluded by PLIP SO4.46: 2 residues within 4Å: Chain G: R.264, H.302 Ligand excluded by PLIP SO4.49: 4 residues within 4Å: Chain H: Y.79, S.80, H.83, K.111 Ligand excluded by PLIP SO4.50: 3 residues within 4Å: Chain H: H.286, D.288, G.289 Ligand excluded by PLIP SO4.51: 3 residues within 4Å: Chain G: K.246 Chain H: S.291, H.292 Ligand excluded by PLIP SO4.52: 2 residues within 4Å: Chain H: R.264, H.302 Ligand excluded by PLIP SO4.53: 4 residues within 4Å: Chain D: S.291, Y.294 Chain H: P.25, V.26 Ligand excluded by PLIP SO4.54: 4 residues within 4Å: Chain H: E.101, S.119, W.120, S.121 Ligand excluded by PLIP SO4.58: 5 residues within 4Å: Chain G: P.250 Chain I: Y.79, S.80, H.83, K.111 Ligand excluded by PLIP SO4.59: 9 residues within 4Å: Chain I: R.160, W.193, C.194, D.195, S.198, Y.200, R.248, D.299, D.301 Ligand excluded by PLIP SO4.60: 3 residues within 4Å: Chain I: S.119, W.120, S.121 Ligand excluded by PLIP SO4.61: 3 residues within 4Å: Chain I: K.102, K.134, H.142 Ligand excluded by PLIP

21 x MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID(Non-covalent)

MES.5: 6 residues within 4Å: Chain A: F.60, F.76, Y.79, S.80, H.83, K.111 Ligand excluded by PLIP MES.6: 7 residues within 4Å: Chain A: D.159, N.162, L.165, C.167, F.183, W.186, Y.190 Ligand excluded by PLIP MES.13: 4 residues within 4Å: Chain B: D.52, F.60, F.76, H.83 Ligand excluded by PLIP MES.14: 7 residues within 4Å: Chain B: D.159, N.162, L.165, C.167, F.183, W.186, Y.190 Ligand excluded by PLIP MES.15: 6 residues within 4Å: Chain B: D.263, R.265, R.271, F.287, W.290, Y.294 Ligand excluded by PLIP MES.20: 5 residues within 4Å: Chain C: M.58, F.60, F.76, Y.79, H.83 Ligand excluded by PLIP MES.21: 7 residues within 4Å: Chain C: D.159, N.162, L.165, C.167, F.183, W.186, Y.190 Ligand excluded by PLIP MES.26: 6 residues within 4Å: Chain D: F.60, F.76, Y.79, S.80, H.83, K.111 Ligand excluded by PLIP MES.27: 7 residues within 4Å: Chain D: D.159, N.162, L.165, C.167, F.183, W.186, Y.190 Ligand excluded by PLIP MES.34: 4 residues within 4Å: Chain E: D.52, F.60, F.76, H.83 Ligand excluded by PLIP MES.35: 7 residues within 4Å: Chain E: D.159, N.162, L.165, C.167, F.183, W.186, Y.190 Ligand excluded by PLIP MES.36: 6 residues within 4Å: Chain E: D.263, R.265, R.271, F.287, W.290, Y.294 Ligand excluded by PLIP MES.41: 5 residues within 4Å: Chain F: M.58, F.60, F.76, Y.79, H.83 Ligand excluded by PLIP MES.42: 7 residues within 4Å: Chain F: D.159, N.162, L.165, C.167, F.183, W.186, Y.190 Ligand excluded by PLIP MES.47: 6 residues within 4Å: Chain G: F.60, F.76, Y.79, S.80, H.83, K.111 Ligand excluded by PLIP MES.48: 7 residues within 4Å: Chain G: D.159, N.162, L.165, C.167, F.183, W.186, Y.190 Ligand excluded by PLIP MES.55: 4 residues within 4Å: Chain H: D.52, F.60, F.76, H.83 Ligand excluded by PLIP MES.56: 7 residues within 4Å: Chain H: D.159, N.162, L.165, C.167, F.183, W.186, Y.190 Ligand excluded by PLIP MES.57: 6 residues within 4Å: Chain H: D.263, R.265, R.271, F.287, W.290, Y.294 Ligand excluded by PLIP MES.62: 5 residues within 4Å: Chain I: M.58, F.60, F.76, Y.79, H.83 Ligand excluded by PLIP MES.63: 7 residues within 4Å: Chain I: D.159, N.162, L.165, C.167, F.183, W.186, Y.190 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Wang, W.K. et al., Malignant brain tumor repeats: a three-leaved propeller architecture with ligand/peptide binding pockets. Structure (2003)

Release Date

2003-08-19

Peptides

Lethal(3)malignant brain tumor-like protein: ABCDEFGHI

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
C

D
A

E
B

F
C

G
A

H
B

I
C

Lethal(3)malignant brain tumor-like protein

Related Entries With Identical Sequence